Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function
Am J Hematol
.
2024 May;99(5):997-1000.
doi: 10.1002/ajh.27286.
Epub 2024 Mar 14.
Authors
Nina Eisenhauer
1
,
Maurizio Miano
2
,
Nora Naumann-Bartsch
3
,
Jörg Leyh
3
4
,
Gianluca Dell'Orso
2
,
Michael Aigner
1
,
Gisela Fecker
3
,
Claas Hinze
5
,
Helmut Wittkowski
5
,
Heiko Bruns
1
,
Jakob Zierk
3
,
Markus Metzler
3
,
Peter D Arkwright
6
,
Frederik Graw
1
,
Andreas Mackensen
1
,
Simon Völkl
1
Affiliations
1
Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany.
2
Hematology Unit, Department of Pediatric Hematology/Oncology, IRCCS Istituto Giannina Gaslini, Genova, Italy.
3
Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany.
4
Department of Pediatric Hematology and Oncology, Klinik Hallerwiese-Cnopfsche Kinderklinik, Nürnberg, Germany.
5
Department of Pediatric Rheumatology and Immunology, University Hospital Münster, Münster, Germany.
6
Lydia Becker Institute of Immunology and Inflammation, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
PMID:
38481382
DOI:
10.1002/ajh.27286
No abstract available
Publication types
Letter
MeSH terms
Apoptosis
Autoimmune Diseases*
Autoimmune Lymphoproliferative Syndrome* / diagnosis
Autoimmune Lymphoproliferative Syndrome* / genetics
Humans
Lymphoproliferative Disorders* / diagnosis
Mutation
T-Lymphocytes
Grants and funding
Bavarian government Hightech Agenda Bavaria
VO1835/3-1/Deutsche Forschungsgemeinschaft
MA1351/12-1/Deutsche Forschungsgemeinschaft